HPB (Hepato-Pancreato-Biliary) Program
Our Hepato-Pancreato-Biliary (HPB) Program is committed to provide the highest standard of care for patients and their families. This care is supported by evidence-based medicine. The program is designed to provide a comprehensive approach to the surgical and medical management of patients with malignancies, neoplasms, and diseases involving the liver, gallbladder, bile ducts, pancreas, and the duodenum. We provide a multidisciplinary team dedicated to the consistent evaluation and improvement of patient-care outcomes across the continuum of inpatient and outpatient care.
Generating Successful Outcomes
Our HPB Program is led by Richard N. Berri, M.D., and Michael J. Jacobs, M.D., (both board-certified surgeons, fellowship-trained in surgical oncology and hepatobiliary surgery), who have consistently provided curative and palliative treatments for patients with cancer. We consistently generate successful outcomes with all HPB procedures, based on a low mortality rate, competitive length of stay, and patient satisfaction because of our collaborative approach to the treatment of every patient.
Our dedicated Hepatobiliary Surgical Team are experts in the treatment of the following:
- Hepatocellular carcinoma, also called malignant hepatoma is the most common type of liver cancer
- Cholangiocarcinoma –cancer of the bile ducts
- Gallbladder cancer
- Metastatic liver tumors of colorectal or other primary sites, are cancers that did not start in the liver (or site) but instead have spread there from the colon or rectum
- Primary liver tumors
Soft tissue Tumors
These cancers are typically found in the breast
- Melanoma, also called soft-tissue melanoma is a fairly rare form of cancer
- Sarcoma, cancer of the soft tissues, is also fairly rare
- Adrenal tumors
- Neuroendocrine tumors are an abnormal mass of tissue from cells of the endocrine (hormonal) and nervous system, which most commonly occur in the intestine
We are one of the only cancer centers in Michigan with the ability to treat peritoneal malignancies with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). This is an extensive surgery, performed by Richard N. Berri, M.D., that includes resection of organs as needed to remove tumors followed by an infusion of heated chemotherapy. This procedure is showing promising results. We treat the following peritoneal malignancies:
- Pseudomyxoma peritonei, an uncommon tumor known for its production of mucin, a heavy protein, in the abdominal cavity, which can build up and compress vital organs
- Colorectal carcinomatosis, a common manifestation of colorectal cancer
- Appendiceal carcinomatosis, a form of appendix cancer
- Primary or Metastatic carcinomatosis, a feature of abdominal cancer
Services We Provide
Focusing on diseases of the liver, gallbladder, bile ducts, pancreas, and duodenum, our services include:
- Minimally invasive laparoscopic surgery
- Laparoscopic Whipple, Dr. Jacobs is the only surgeon performing this procedure in Michigan
- Complex HPB surgery
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
- Advanced Interventional Radiology
- Radiofrequency Ablation (RFA)
- Individualized care plans for each patient
- Robotic assisted general surgery
- Utilization of clinical pathways
- Protocols to address pain control
- State-of-the-art gastroenterology, including complex Endoscopic Retrograde Cholangiopancreatography (ERCP) and endoscopic ultrasound
- Portal vein embolization to allow for surgical resection of advanced liver tumors
- Multidisciplinary team approach with surgeons, gastroenterologists, radiologists, medical and radiation oncologists
- Weekly Tumor Board meetings.
We maintain continuing communication with referring physicians and ensure involvement in their patient's medical management throughout the process. Our goal is to successfully attend to our patients' needs and then return them to their referring physicians.
How to make an appointment?
Call our toll free number and let one of our Cancer Care Coordinators assist you 1-866-246-4673 to schedule an appointment.
Pancreatic Cancer Program
What you should know about our pancreatic cancer program
Our pancreatic cancer unit has its own program, led by Richard N. Berri, M.D., and Michael J. Jacobs, M.D. The team follows a multidisciplinary National Comprehensive Cancer Network (NCCN) based approach with an emphasis on neoadjuvant chemotherapy, radiation and definitive surgical resection, including the management of complex pancreatic resection.
Your physician has referred you to our surgeons because of their expertise in this field. We maintain continuing communication with your referring physicians and ensure their involvement in your medical management throughout the process.
We have a dedicated inpatient surgical oncology floor where all our cancer patients receive exceptional care in the postoperative setting by compassionate, specially trained nurses.
Certain cancer tumors can be removed through surgery. Sometimes surgery is a stand-alone treatment option. For other people, it may be combined with radiation and/or chemotherapy. Under Richard N. Berri, M.D., Director of Surgical Oncology, our goal is to provide the most comprehensive and current surgical evaluation and treatment to patients with malignancies that can be treated surgically:
- Small bowel
- Colon, rectum, anus
- Carcinoid tumors of the GI tract
- Hepatocellular carcinoma
- Gallbladder cancer
- Metastatic liver tumors of colorectal or other primary
- Primary liver tumors
Soft tissue tumors:
- Adrenal tumors
- Neuroendocrine tumors
- Pseudomyxoma peritonei
- Colorectal carcinomatosis
- Appendiceal carcinomatosis
- Primary peritoneal carcinomatosis
- Carcinomatosis of designated primary
Our Surgical Oncology section offers patients a multidisciplinary assessment through the collaboration of various specialists who provide a consensus recommendation on the optimal treatment options. These specialists meet together bi-monthly to discuss all cases in a multidisciplinary Tumor Board. The team includes:
- Surgical Oncologist
- Medical Oncologist
- Radiation Oncologist
- General Surgeon
- Program staff
The overall goal of the section is to optimize the quality of care in line with national guidelines based on the National Comprehensive Cancer Network (NCCN) and to improve outcomes using a multidisciplinary approach with experts in their respective fields
Stereotactic radiosurgery, or SRS, is the most precise method of administering a dose of radiation to an area inside the body, in order to eliminate a tumor or other abnormality. It has been used for some time by neurosurgeons to treat vascular abnormalities and tumors in the brain, both benign and malignant. SRS's ultra-high precision destroys tumors with high doses of radiation, while sparing the surrounding healthy tissue. In this way SRS provides a noninvasive alternative to surgery, allowing treatment of some otherwise inoperable tumors.
Recent advances in imaging, patient positioning, and targeting have all made SRS appropriate for the treatment of some cancers in other parts of the body as well. Diagnostic images taken before treatment—including computed tomography (CT), positron emission tomography (PET), and magnetic resonance imaging (MRI)—help determine where to aim the radiation. The beams are shaped to match the contours of the tumor and are delivered from many different angles around the body, all converging precisely at the planned target location.
Unlike other forms of radiation therapy that might be delivered over a period of weeks, SRS treatments are usually completed in a single day. (Another treatment method, stereotactic radiotherapy, or SRT, involves just a few treatment sessions.) SRS is most often delivered as an outpatient procedure.
If you or a loved one has been diagnosed with a condition that may require surgery, you owe it to yourself to learn about all of your medical options, including the most effective, least invasive surgical treatments available.
The da Vinci® Robotic Surgical System, available via numerous St. John Providence Health System surgeons, provides an alternative to traditional open surgery, putting a surgeon's hands at the controls of a state-of-the-art robotic platform. The da Vinci Robotic System enables surgeons to perform even the most complex and delicate procedures through very small incisions with unmatched precision.
For the patient, benefits may include:
- Significantly less pain
- Less blood loss
- Less scarring
- Shorter recovery time
- A faster return to normal daily activities
Learn more about our surgical oncology services. Call 1-866-246-4673
- Pancreatic Cancer Action Network
- The Lustgarten Foundation for Pancreatic Cancer and Research
- The National Pancreas Foundation